Minesh Mehta, MD, discusses positive findings from the phase 3 METIS trial investigating TTFields therapy for brain metastases in NSCLC.
Minesh Mehta, MD
Advertisement
Minesh Mehta, MD, is a radiation oncologist at the Miami Cancer Institute, Baptist Health South Florida.
Articles by Minesh Mehta, MD
Advertisement
Latest Updated Articles
Mehta on the Phase 3 METIS Trial of TTFields for Brain Metastases in NSCLCPublished: June 6th 2024 | Updated:
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
4
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
5
